Ifakara Health Institute (IHI) is a leading research organization in Africa with a strong track record in developing, testing and validating innovations for health. Driven by a core strategic mandate for research, training and services, the Institute’s work now spans a wide spectrum, covering biomedical and ecological sciences, intervention studies, health-systems research and policy translation. Based on long-lasting
research partnerships, IHI has a strong track record for clinical trials in Tanzania, primarily in the field of malaria and tuberculosis. Tuberculosis research at IHI covers clinical trials on new vaccines and new treatment regimens for TB, as well as evaluation of new diagnostics, immunology, co-morbidities, and molecular epidemiology for TB.